Latest Content

Sasanlimab Improves Event-Free Survival for Some With Bladder Cancer

January 13th 2025, 10:00pm

By Alex Biese

Article

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Delving into Subcutaneous Versus Intravenous Opdivo in Solid Tumors

January 13th 2025, 8:07pm

By Ryan Scott

Video

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors.

Always Bring a Second Set of Ears to Your Oncology Checkup!

January 13th 2025, 6:00pm

By Linda Cohen

Article

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling overwhelmed and alone.

HIPEC May Not Improve Outcomes for Recurrent Epithelial Ovarian Cancer

January 13th 2025, 4:00pm

By Spencer Feldman

Article

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer.

SBRT May Be a Viable Option for Patients With Liver Cancer

January 13th 2025, 2:00pm

By Spencer Feldman

Video

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

The Gift of a Second Chance After My Stem Cell Transplant

January 12th 2025, 7:00pm

By Aswita Tan-McGrory

Article

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

FDA Grants Fast Track Designation for Abenacianine in Lung Cancer Surgery

January 11th 2025, 7:00pm

By Spencer Feldman

Article

The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally invasive surgery.

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval

January 11th 2025, 3:00pm

By Ryan Scott

Article

Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

The Impact of Yescarta on Long Term Quality of Life in R/R Follicular Lymphoma

January 10th 2025, 10:00pm

By Ryan Scott

Video

Dr. Sattva S. Neelapu discusses how the CAR-T therapy Yescarta impacts the quality of life of patients with R/R indolent non-Hodgkin lymphoma.

P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia

January 10th 2025, 8:00pm

By Ryan Scott

Article

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.

Learning to ‘Let it Be’ After Poor Test Results

January 10th 2025, 6:00pm

By Chester Freeman

Article

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.

Peter Yarrow Dies of Bladder Cancer, Dick Vitale Cleared for ESPN Return and More

January 10th 2025, 4:00pm

By Alex Biese

Article

From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, here is this week’s news.

First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer

January 10th 2025, 2:00pm

By Alex Biese

Article

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.

FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma

January 9th 2025, 10:00pm

By Ryan Scott

Article

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with relapsed/refractory osteosarcoma.

Laparoscopic Wedge and Endoscopic Resection Are Safe, Feasible in Gastric GISTs

January 9th 2025, 8:00pm

By Ryan Scott

Article

Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric gastrointestinal stromal tumors.